Yes, depression is a mental illness. It is formally classified as a mental disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the standard reference used by clinicians worldwide. Roughly 5.7% of adults globally experience depression, making it one of the most common mental health conditions.
But the question behind the question is usually more nuanced: How is depression different from just feeling sad? What makes it a medical condition rather than an emotional response to life? The answer lies in its duration, its effect on the brain, and its reach into nearly every system in the body.
How Depression Differs From Sadness
Sadness is a normal emotion. It comes after a breakup, a job loss, or a death in the family, and it fades as you process the event and adapt. Clinical depression is different because it persists practically every day for at least two weeks and involves a cluster of symptoms beyond low mood alone. To meet the diagnostic threshold, you need at least five of nine specific symptoms, and one of them must be either a persistently depressed mood or a noticeable loss of interest in things you used to enjoy.
The other symptoms include disrupted sleep, fatigue or low energy, difficulty concentrating, feelings of worthlessness or excessive guilt, changes in appetite or weight, slowed or agitated movement, and thoughts of suicide. These aren’t occasional bad days. They show up most of the day, nearly every day, and they interfere with your ability to work, maintain relationships, or take care of yourself.
What Happens in the Brain
Depression involves measurable changes in brain structure and chemistry. In a meta-analysis of 12 studies, the hippocampus, a region involved in memory and emotional regulation, was consistently smaller in people with depression compared to healthy controls. The degree of shrinkage was directly proportional to how many depressive episodes a person had experienced and how long they went untreated. At the cellular level, this shrinkage comes from reduced branching and connectivity between neurons, not from neurons dying off entirely.
The brain’s chemical signaling is also disrupted. People with depression tend to have lower levels of key signaling molecules like serotonin and norepinephrine. Brain imaging of untreated depression has revealed elevated activity of an enzyme that breaks down these molecules faster than normal. At the same time, levels of a protein that helps neurons grow and form new connections (called BDNF) are significantly lower in untreated patients compared to treated patients or healthy controls. Postmortem studies of people who died by suicide found markedly reduced levels of this same growth protein.
Stress hormones play a role too. People with depression consistently show elevated cortisol, the body’s primary stress hormone. Over time, high cortisol damages the hippocampus specifically because that region has a dense concentration of receptors for stress hormones, making it unusually vulnerable.
Depression Is a Physical Illness Too
One reason people question whether depression is “really” an illness is that they associate it only with emotional symptoms. In practice, physical symptoms are extremely common and are often the first thing that brings someone to a doctor. Chronic joint pain, back pain, headaches, stomach problems, and general muscle aches frequently accompany depression. Fatigue, disrupted sleep, appetite changes, and slowed physical movement are so central to the condition that they’re part of the diagnostic criteria.
These aren’t psychosomatic complaints. The same neurotransmitter systems involved in mood regulation also modulate pain perception throughout the body. When those systems malfunction, you feel it physically.
What Causes It
Depression doesn’t have a single cause. Twin studies estimate that about one-third of the risk comes from genetics. The remaining two-thirds is environmental, which means life circumstances interact with biological vulnerability to trigger episodes.
Environmental triggers fall into three broad categories. Acute life events, particularly interpersonal losses like the death of a loved one or the end of a relationship, are among the strongest triggers. Most major depressive episodes are preceded by a stressful life event. Chronic stress also plays a significant role: poverty, unemployment, single-parent status, racial discrimination, and living in neighborhoods with high crime or noise all increase risk. Finally, early adversity carries lasting effects. Childhood sexual or physical abuse, parental substance use, family violence, loss of a parent, and growing up without a close relationship with a caring adult all raise the likelihood of depression later in life.
None of these causes alone is sufficient. A person with strong genetic loading might develop depression after a relatively minor stressor, while someone with no family history might develop it after prolonged, severe adversity. The illness emerges from the interaction.
The DSM-5 Classification
The DSM-5 doesn’t treat depression as a single condition. It recognizes several depressive disorders:
- Major depressive disorder, the most commonly diagnosed form, defined by discrete episodes lasting at least two weeks
- Persistent depressive disorder (dysthymia), a lower-grade but longer-lasting form that continues for two years or more
- Premenstrual dysphoric disorder, tied to the menstrual cycle
- Disruptive mood dysregulation disorder, diagnosed in children and adolescents
- Depressive disorder due to another medical condition, where a physical illness like hypothyroidism or a neurological condition directly produces depressive symptoms
Each of these has specific criteria, but they all share the core features of persistent low mood, loss of pleasure, and functional impairment. The existence of a depressive disorder triggered by medical conditions actually reinforces the biological nature of the illness: when you alter brain chemistry through a physical disease, depression can follow.
How It’s Screened and Measured
Doctors often use a short questionnaire called the PHQ-9 to screen for depression. It asks nine questions corresponding to the nine diagnostic symptoms, scored from 0 (not at all) to 3 (nearly every day). Scores of 5, 10, 15, and 20 correspond to mild, moderate, moderately severe, and severe depression. A score of 10 or higher correctly identifies major depression about 88% of the time. Scores below 5 almost always indicate no depressive disorder.
This tool doesn’t replace a full clinical evaluation, but it illustrates something important: depression can be measured with reasonable precision. It’s not a vague label applied to people who seem unhappy. It’s a condition with identifiable symptoms, predictable severity levels, and quantifiable thresholds.
How Treatment Works
The two main treatment approaches are psychotherapy and antidepressant medication, and both are effective. In clinical trials, both approaches produced roughly a 50% reduction in depressive symptoms over 3 to 12 months. Some people respond better to one than the other, and combining the two often works better than either alone.
Antidepressants work by increasing the availability of signaling molecules like serotonin and norepinephrine in the brain. Over time, this triggers a cascade that boosts production of the growth protein (BDNF) that depression depletes, helping neurons rebuild connections. This is why antidepressants typically take several weeks to produce their full effect: the immediate chemical change is just the first step in a longer process of neural repair.
Therapy, particularly cognitive behavioral therapy, works by changing patterns of thinking and behavior that maintain depressive episodes. It’s not just talking about your feelings. It involves structured techniques for identifying distorted thought patterns, gradually re-engaging with activities, and building skills to prevent relapse. The fact that therapy produces measurable changes in brain function on imaging scans further underscores that depression is a brain-based illness, one that can be treated through multiple pathways.
Who It Affects
Depression is not evenly distributed. Women are affected at higher rates than men: 6.9% of women compared to 4.6% of men globally. Adults over 70 experience depression at a rate of about 5.9%. These differences likely reflect a combination of hormonal factors, differences in stress exposure, and social conditions rather than any single explanation.
The scope of the problem is enormous. With roughly 4% of the entire global population affected at any given time, including children and adolescents, depression ranks among the most widespread health conditions on the planet. It is not a character flaw, a sign of weakness, or a choice. It is a medical condition with identifiable biological markers, known risk factors, effective treatments, and serious consequences when left untreated.